Abstract
Recent prospective studies of hospital-acquired acute renal failure have revealed it to be a serious illness.1,2The development of hospital-acquired acute renal failure is associated with a sixfold increase in risk of dying. In fact, patients who develop an elevation of serum creatinine concentration greater than 3 mg/dl have a mortality rate of 64%. Development of this condition also has a marked impact on the length of stay of a patient in hospital. One recent report demonstrated that the development of acute renal failure increased a patient’s length of stay in the hospital an average of 13–23 days. The most common etiologies of hospital-acquired acute renal failure include aminoglycoside nephrotoxicity, radiocontrast exposure, volume depletion, and septic shock. These etiologies highlight the role of both toxic and ischemic processes in clinically relevant acute renal failure. Prevention of hospital-acquired acute renal failure is, therefore, critically important, not only to diminish the mortality rate associated with this disease process, but also to limit the cost of hospital care. For example, a carefully done retrospective analysis of 1756 patients receiving aminoglycosides was undertaken to determine the economic impact of aminoglycoside associated nephrotoxicity.3 An incidence rate of 7% in these patients was identified for aminoglycoside-associated nephrotoxicity. In this study, the additional cost of treating this complication in these patients totaled approximately $2500 per episode.
Keywords
- Glomerular Filtration Rate
- Acute Renal Failure
- Renal Blood Flow
- Cyclosporine Nephrotoxicity
- Radiocontrast Agent
These keywords were added by machine and not by the authors. This process is experimental and the keywords may be updated as the learning algorithm improves.
This is a preview of subscription content, log in via an institution.
Buying options
Tax calculation will be finalised at checkout
Purchases are for personal use only
Learn about institutional subscriptionsPreview
Unable to display preview. Download preview PDF.
References
Shusterman, N., Strom, B.L., Murray, T.G., Morrison, G., West, S.L., and Maislin, G., 1987, Risk factors and outcome of hospital-acquired acute renal failure, Am. J. Med. 83:65–71.
Hou, S.H., Bushinsky, D.A., Wish, J.B., Cohen, J.J., and Harrington, J.T., 1983, Hospitalacquired renal insufficiency: A prospective study, Am. J. Med. 74:243–248.
Eisenberg, J.M., Koffer, H., Glick, H.A., Connell, M.L., Loss, L.E., Talbot, G.H., Shusterman, N.H., and Strom, B.L., 1987, What is the cost of nephrotoxicity associated with aminoglycosides? Ann. Intern. Med. 107:900–909.
Moran, S.M. and Myers, B.D., 1985, Pathophysiology of protracted acute renal failure in man, J. Clin. Invest. 76:1440–1448.
The Canadian Multicentre Transplant Study Group, 1986, A randomized clinical trial of cyclosporine in cadaveric renal transplantation, N. Engl. J. Med. 314:1219–1225.
Flechner, S.M., Payne, W.D., Van Buren, C., Kerman, R., and Kahan, B.D., 1983, The effect of cyclosporine on early graft function in human renal transplantation, Transplantation 36:268–272.
Bia, M.J. and Tyler, K.A., 1987, Effect of cyclosporine on renal ischemic injury, Transplantation 43:800–804.
Kahan, B.D. (ed.), 1985, Cyclosporine-associated renal injury, Transpl. Proc. 17:185-196.
Sommer, B.G., Innes, J.T., Whitehurst, R.M., Sharma, H.M., and Ferguson, R.M., Cyclosporine-associated renal arteriopathy resulting in loss of allograft function, Am. J. Surg. 149: 756-764.
Myers, B.D., Ross, J., Newton, L., Luetscher, J., and Perlroth, M., 1984, Cyclosporineassociated chronic nephrology, N. Engl. J. Med. 311:699–705.
Palestine, A.G., Austin, H.A., Ill, Balow, J.E., Antonovych, T.T., Sabnis, S.G., Preuss, H.G., and Nussenblatt, R.B., 1986, Renal histopathologic alterations in patients treated with cyclosporine for uveitis, N. Engl. J. Med. 314:1293–1298.
Myers, B.D., Sibley, R., Newton, L., Tomlanovich, S.J., Boshkos, C., Stinson, E., Luetscher, J.A., Whitney, D.J., Krasny, D., Coplon, N.S., and Perlroth, M.G., 1988, The long-term course of cyclosporine-associated chronic nephropathy, Kidney Int. 33:590–600.
European Multicentre Trial, 1982, Cyclosporine A as sole immunosuppressive agent in recipients of kidney allografts from cadaver donors, Lancet 2:57–60.
Najarian, J.S., Strand, M., Fryd, D.S., et al. , 1983, Comparison of cyclosporine versus azathioprine-antilymphocyte globulin in renal transplantation, Transpl. Proc. 15:438–441.
Adu, D., Turney, M.J., et al. , 1983, Hyperkalemia in cyclosporine-treated renal allograft recipients, Lancet, 2:370–372.
Bantle, J.P., Nath, K.A., Sutherland, D.E.R., Najarian, J.S., and Ferris, T.F., 1985, Effect of cyclosporine on the renin-angiotensin system and potassium excretion in renal transplant recipients, Arch. Intern. Med. 145:505–508.
June, C.H., Thompson, C.B., Kennedy, M.S., Nims, J., and Thomas, E.D., 1985, Profound hypomagnesemia and renal magnesium wasting associated with the use of cyclosporine for marrow transplantation, Transplantation 39:620–624.
Barton, C.H., Vaziri, N.D., Martin, D.C., etal., 1987, Hypomagnesemia and renal magnesium wasting in renal transplant recipients receiving cyclosporine, Am. J. Med. 83:693–699.
Bellet, M., Carbol, C., Sassano, P., Leger, P., Corvol, P., and Menard, J., 1985, Systemic hypertension after cardiac transplantation: Effect of cyclosporine on the renin-angiotensin-aldosterone system, Am. J. Cardiol. 56:927–931.
Baxter, C.R., Duggin, G.G., Willis, N.S., Hall, B.M., Horvath, J.S., and Tiller, D.J., 1982, Cyclosporine A-induced increases in renin storage and release, Res. Commun. Chem. Pathol. Pharmacol. 37:305–312.
Murray, B.M., Paller, M.S., and Ferris, T.F., 1985, Effect of acute and chronic cyclosporine administration on renal hemodynamics in conscious rats, Kidney Int. 28:767–774.
Thompson, M.E., Shapiro, A.P., Johnson, A.M., Reeves, R., Itzkoff, J., Ginchereau, E., Hardesty, R.L., Griffith, B.L., Bahnson, H.T., and McDonald, R., Jr., 1983, New onset of hypertension following cardiac transplantation: A preliminary report and analysis, Transpl. Proc. 15:2573–2577.
Chapman, J.R., Marcen, R., Arias, M., Raine, A.E.G., Dunnill, M.S., and Morris, P.J., 1987, Hypertension after renal transplantation, Transplantation 43:860–864.
Maurer, G., Loosli, H.R., Schrier, E., and Keller, B., 1984, Disposition of cyclosporine in several animal species and man. Structural elucidation of its metabolites, Drug. Disposal Metab. 12:120–126.
Jensen, C.W.B., Flechner, S.M., Van Buren, C.T., Frazier, O.H., Cooley, D.A., Lorber, M.I., and Kahan, B.D., 1987, Exacerbation of cyclosporine toxicity by concomitant administration of erythromycin, Transplantation 43:263–270.
White, D.J.G., Blatchford, N.R., and Cauwenbergh, G., 1984, Cyclosporine and ketoconazole, Transplantation 37:214–215.
Modry, D.L., Stinson, E.B., Oyer, P.E., Jamieson, S.W., Baldwin, J.C., etal., 1985, Acute rejection and massive cyclosporine requirements in heart transplant recipients treated with rafampin, Transplantation 39:313–314.
Freeman, D.J., Laupacis, A., Keown, P.A., Stiller, C.R., and Carruthers, S.G., 1984, Evaluation of cyclosporin-phenytoin interaction with observations on cyclosporin metabolites, Br. J. Clin. Pharmacol. 18:887–893, 1984.
Veremus, S.A., Maddux, M.S., Pollak, R., and Mozes, M.F., 1987, Subtherapeutic cylosporine concentrations during nafcillin therapy, Transplantation 43:913–915.
Ross, W.B., Roberts, D., Griffin, P.J.A., and Salaman, J.R., 1986, Cyclosporine interaction with danazol and norethisterone, Lancet 2:330.
Moller, B.B. and Ekelund, B., 1985, Toxicity of cyclosporine during treatment of androgens, N. Engl. J. Med. 313:1416.
Maurer, G., 1985, Metabolism of cyclosporine, Transplant Proc. 17(Suppl 1) 19–26.
Renton, K.W., 1985, Inhibition of hepatic microsomal drug metabolism by the calcium channel blockers diltiazem and verapamil, Biochem. Pharmacol, 34:2, 549-553.
Grino, J.M., Sebate, I., Castelao, A.M., and Alsina, J., 1986, Influence of diltiazem on cyclosporine clearance, Lancet 1:1387.
Bourbigot, B., Guiserix, J., Bressollette, L., Morin, J.F., and Cledes, J., 1986, Nicardipine increases cyclosporine blood levels, Lancet 1:1447.
Lindholm, A. and Henricsson, S., 1987, Verapamil inhibits cyclosporine metabolism, Lancet 1: 1262–1263.
Iaina, A., Herzog, D., Cohen, D., et al. , 1986, Calcium entry-blockade with verapamil in cyclosporine A plus ischemia induced acute renal failure in rats, Clin. Nephrol. 25(Suppl 1): S168–S170.
Puurunen, J. and Pelkonen, O., 1984, Cimetidine inhibits microsomal drug metabolism in the rat, Eur. J. Pharmacol. 5:214–215.
Wadhwa, N.K., Schroeder, T.J., O’Flaherty, E., Pesce, A.J., Myre, S.A., and First, M.R., 1987, The effect of oral metoclopramide on the absorption of cyclosporine, Transplantation 43: 211–213.
Kennedy, M.S., Deeg, H.J., Siegel, M., Crowley, J.J., Storb, R., and Thomas, E.D., 1983, Acute renal toxicity with combined use of amphotericin B and cyclosporine after marrow transplantation, Transplantation 35:211–215.
Whiting, P.H., Simpson, J.G., Davidson, R.J.L., and Thomson, A.W.,1982, The toxic effects of combined administration of cyclosporin A and gentamicin, Br. J. Exp. Pathol. 63:554–561.
Dale, B.M., Sage, R.E., Norman, J.E., Barber, S., and Kotasek, D., 1985, Bone marrow transplantation following treatment with high-dose melphalan, Transplant Proc. 17(2) 1711–1713.
Thompson, J.F., Chalmers, D.H.K., Hunnisett, A.G.W., Wood, R.F.M., and Morris, P.J., 1983, Nephrotoxicity of trimethoprim and cotrimoxazole in renal allograft recipients treated with cyclosporin, Transplantation 36:204–206.
Jackson, N.M., Hsu, C.H., Visscher, G.E., Venkatachalam, M.A., and Humes, H.D., 1987, Alterations in renal structure and function in a rat model of cyclosporine nephrotoxicity, J. Pharmacol. Exp. Ther. 242:749–756.
Murray, B.M., Paller, M.S., and Ferris, T.F., 1985, Effects of cyclosporine administration on renal hemodynamics in conscious rats, Kidney Int., 28:767–774.
Moss, N.G., Rowell, S.L., and Falk, R.J., 1985, Intravenous cyclosporine activates afferent and efferent renal nerves and causes sodium retention in innervated kidneys in rats, Proc. Natl. Acad. Sci. USA 82:8222–8226.
Xue, H., Bukoski, R.D., McCarron, D.A., and Bennett W.M., 1987, Induction of contraction in isolated rat aorta by cyclosporine, Transplantation 43:715–718.
Pfeilschifter, J. and Ruegg, U.T., 1987, Cyclosporin A augments angiotensin II-stimulated rise in intracellular free calcium in vascular smooth muscle cells, Biochem. J. 248:883–887.
Barros, E.J.G., Boim, M.A., Ajzen, H., Ramos, O.L., and Schor, N., 1987, Glomerular hemodynamics and hormonal participation on cyclosporine nephrotoxicity, Kidney Int. 32:19–25.
Kaskel, F.J., Devarajan, P., Arbeit, L.A., Partin, J.S., and Moore, L.C., 1987, Cyclosporine nephrotoxicity: Sodium excretion, autoregulation, and angiotensin II, Am. J. Physiol., 252 (Renal Fluid Electrolyte Physiol. 21):F733–F744.
Perico, N., Benigni, A., Zoja, C., Delaini, F., and Remuzzi, G., 1986, Functional significance of exaggerated renal thromboxane A2 synthesis induced by cyclosporine A, Am. J. Physiol. 251 (Renal Fluid Electrolyte Physiol. 20):F581–F587.
Coffman, T.M., Carr, D.R., Yarger, W.E., and Klotman, P.E., 1987, Evidence that renal prostaglandin and thromboxane production is stimulated in chronic cyclosporine nephrotoxicity, Transplantation 43:282–285.
Elzinga, L., Kelley, V.E., Houghton, D.C., and Bennett, W.M., 1987, Modification of experimental nephrotoxicity with fish oil as the vehicle for cyclosporine, Transplantation 43:271–274.
Kurtz, A., Pfeilschifter, J., Kuhn, K., and Koche, K.M., 1987, Biochem. Biophys. Res. Commun. 147:542–549.
Zoja, C., Furci, L., Ghilardi, F., Zilio, P., Benigni, A., and Remuzzi, G., 1986, Cyclosporineinduced endothelial cell injury, Lab. Invest. 55:455–462, 1986.
Grace, A.A., Barradas, M.A., Mikhaildis, D.P., Jeremy, J.Y., Moorhead, J.F., Sweny, P., and Dandona, P., 1987, Cyclosporine A enhances platelet aggregation, Kidney Int. 32:889–895.
Bertani, T., Perico, N., Abbate, M., Battaglia, C., and Remuzzi, G., 1987, Renal injury induced by long-term administration of cyclosporine A to rats, Am. J. Pathol. 127:569–579.
Huang, W.Y., Lipsey, A.I., and Cheng, M.H., 1987, Comparison of cyclosporine determinations in whole blood by three different methods, Am. J. Clin. Pathol. 87:528–532.
Diethelm, A.G., 1986, Clinical diagnosis and management of the renal transplant recipient with cyclosporine nephrotoxicity, Transpl. Proc. 18:82–87.
Carpenter, C.B., Milford, E.L., Kirkman, R.L., Strom, T.B., Lazarus, J.M., and Tilney, N.L., 1985, Stability of renal allograft recipients after conversion from cyclosporine to azathioprine, Transpl. Proc. 17:261–265.
Flechner, S.M., Lorber, M., Van Buren, C., Kerman, R., and Kahan, B.D., 1985, The case against conversion to azathoprine in cyclosporine-treated renal recipients, Transpl. Proc. 17:276– 281.
Simmons, R.L., Canafax, D.M., Strand, M., Ascher, N.L., Payne, W.S., Sutherland, D.E.R., and Najarian, J.S., 1985, Management and prevention of cyclosporine nephrotoxicity after renal transplantation: Use of low doses of cyclosporine, azathioprine, and prednisone, Transpl. Proc. 17:266–275.
Lorber, M.I., Flechner, S.M., Van Buren, C.T., Sorensen, K., Kerman, R.H., and Kahan, B., 1987, Cyclosporine Toxicity: The effect of combined therapy using cyclosporine, azathioprine and prednisone, Am. J. Kidney Dis. 9:476–484.
Moore, R.D., Smith, C.R., Lipsky, T.J., Mellits, E.D., and Lietman, P.S., 1984, Risk factors for nephrotoxicity in patients treated with aminoglycosides, Ann. Intern. Med. 100:352–357.
Cabrera, J. Arroyo, V., Ballesta, A., Rimola, A., Gual, J., Elena, M., and Rodes, J., 1982, Aminoglycoside nephrotoxicity in cirrhosis. Value of urinary B2-microglobulin to discriminate functional renal failure from acute tubular damage, Gastroenterology 82:97–105.
Kourilsky, O., Solez, K., Morel-Maroger, L., Whelton, A., Duhoux, P., and Sraer, J.D., 1982, The pathology of acute renal failure due to interstitial nephritis in man, with comments on the role of interstitial inflammation and sex in gentamicin nephrotoxicity, Medicine 61:258–268.
Lietman, P.S. and Smith, C.R., 1983, Aminoglycoside nephrotoxicity in humans, Rev. Infect. Dis. 5:S284.
Kahlmeter, G. and Dahlager, J., 1984, Aminoglycoside toxicity—A review of clinical studies published between 1975 and 1982, J. Antimicrob. Chemother. 13(Suppl A)9–22.
Lerner, S.A., Seligsohn, R., and Matz, G.J., 1977, Comparative clinical studies of ototoxicity and nephrotoxicity of amikacin and gentamicin, Am. J. Med. 62:919.
Holm, S.E., Hill, B., Lowestad, R., Mailer, R., and Vikerfors, T.A., 1983, A prospective randomized study of amikacin and gentamicin in serious injections with focus on efficacy, toxicity and duration of serum levels above the MIC, J. Antimicrob. Chemother. 12:393–402.
DeBroe, M.E., Paulus, G.J., Verprooten, G.A., Roels, F., Buyssens, N., Weden, R., VanHoot, F., and Tulkens, P.M., 1984, Early effects of gentamicin, tobramycin and amikacin on the human kidney, Kidney Int. 25:643–652.
Luft, F.C., Yum, M.N., and Kleit, S.A., 1976, Comparative nephrotoxicities of netilmicin and gentamicin in rats, Antimicrob. Agents Chemother. 10:845–849.
Soberon, L., Bowman, R.L., Pasoriza-Munoz, E., and Kaloyanides, G.J., 1979, Comparative nephrotoxicities of gentamicin, netilmicin and tobramycin in the rat, J. Pharmacol. Exp. Ther. 210:334–343.
Lerner, A.M., Cone, L.A., Jansen, W., Reyes, M.P., Blair, D.C., Wright, G.E., and Lorber, R.R., 1983, Randomized, controlled trial of the comparative efficacy, auditory toxicity and nephrotoxicity of tobramycin and netilmicin, Lancet 1:1123–1126.
Daschner, F.D., Just, A.M., Jansen, W., and Lorber, R., 1984, Netilmicin versus tobramycin and multicentre studies, J. Antimicrob. Chemother. 13(A)37–45.
Knauss, T.C., Weinberg, J.M., and Humes, H.D., 1983, Alterations in renal cortical phospholipid content induced by gentamicin: Time course, specificity and subcellular localization, Am. J. Physiol. 224:F535–F546.
Schwertz, D.W., Kreisberg, J.I., and Venkatachalam, M.A., 1984, Effects of aminoglycosides on proximal tubule brush border membrane phosphatidylinositol-specific phospholipase C, J. Pharmacol. Exp. Ther. 231:48.
Sastrasinh, M., Knauss, T.C., Weinberg, J.M., and Humes, H.D., 1982, Identification of the aminoglycoside binding site in rat renal brush border membranes, J. Pharmacol. Exp. Ther. 222: 350–358.
Schacht, J., 1979, Isolation of an aminoglycoside receptor from guinea pig inner ear tissues and kidney, Arch. Otorhinolaryngol. 224:129–134.
Schibeci, A. and Schacht, J., 1977, Action of neomycin on the metabolism of polyphosphoinositides in the guinea pig kidney, Biochem. Pharmacol. 26:1769–1774.
Marche, P., Koutouzov, S., and Girard, A., 1983, Impairment of membrane phosphoinositide metabolism by aminoglycoside antibiotics: Streptomycin, amikacin, kanamycin, dibekacin, gentamicin and neomycin, J. Pharmacol. Exp. Ther. 227:415–420.
Berridge, M.J., 1984, Inositol triphosphate and diacylglycerol as second messengers, Biochem. J. 220:345–360.
Kirschbaum, B.B., 1984, Interactions between renal brush border membranes and polyamines, J. Pharmacol. Exp. Ther. 229:409–416.
Josepovitz, C., Pastoriza-Munoz, E., Timmerman, D., Scott, M., Feldman, S., and Kaloyanides, G.J., 1982, Inhibition of gentamicin uptake in rat renal cortex in vivo by aminoglycosides and organic polycations, J. Pharmacol. Exp. Ther. 223:314–321.
Brasseur, R., Laurent, G., Raysschaert, J.M. and Tulkens, P., 1984, Interactions of aminoglycoside antibiotics with negatively charged lipid layers: Biochemical and conformational studies, Biochem. Pharmacol. 33:629–637.
Weinberg, J.M. and Humes, H.D., 1980, Mechanisms of gentamicin-induced dysfunction of renal cortical mitochondria. I. Effects on mitochondrial respiration, Arch. Biochem. Biophys. 205: 222–231.
Weinberg, J.M., Harding, P.G., and Humes, H.D., 1980, Mechanisms of gentamicin-induced dysfunction of renal cortical mitochondria. II. Effects on monovalent cation transport, Arch. Biochem. Biophys. 205:232–239.
Walker, P.D. and Shah, S.V., 1987, Gentamicin enhanced production of hydrogen peroxide by renal cortical mitochondria, Am. J. Physiol. 253:C495–C499.
Walker, P.D. and Shah, S.V., 1988, Evidence suggesting a role for hydroxyl radical in gentamicin- induced acute renal failure in rats, J. Clin. Invent. 81:334–341.
Josepovitz, J.C., Pastoriza-Munoz, E., Timmerman, D., Scott, M., Feldman, S., and Kaloyanides, G.J., 1982, Inhibition of gentamicin uptake in rat renal cortex in vivo by aminoglycosides and organic polycations, J. Pharmacol. Exp. Ther. 223:314–321.
Humes, H.D., Sastrasinh, M., and Weinberg, J.M., 1984, Calcium is a competitive inhibitor of gentamicin-renal membrane binding interactions and dietary calcium supplementation protects against gentamicin nephrotoxicity, J. Clin. Invest. 73:134–147.
Bennett, W.M., Elliott, C.W., Houghton, D.C., Gilbert, D.N., Defehr, J., and McCarron, D.A., 1982, Reduction of experimental gentamicin neophrotoxicity in rats by dietary calcium loading, Antimicrob. Agents Chemother. 22:503–512.
Williams, P.D., Hottendorf, G.H., and Bennett, D.B., 1986, Inhibition of renal membrane binding and nephrotoxicity of aminoglycosides, J. Pharmacol. Exp. Ther. 237:919–925.
Swanson, D.P., Dick, T.J., Simms, S.M., etal., 1985, Product selection criteria for intravascular ionic contrast media, Clin. Pharmacol. 4:527–538.
Grainger, R.G., 1980, Osmolality of intravascular radiological contrast media, Br. J. Radiol. 53: 739–746.
Dawson, P., 1984, New contrast agents: Chemistry and pharmacology, Invest. Radiol. 19(Suppl) S298–S300.
Golman, K., Olivecrona, H., Gustafson, C., et al. , 1980, Excitation and depression of nonanesthetized rabbits following injection of contrast media into the subarachnoid space, Acta. Radiol. 362(Suppl):83–86.
Humes, H.D. and Nguyen, V.D., 1987, Acute renal failure and toxic nephropathy, Contemp. Nephr. 4:401–462.
Arend, L.J., Bakris, G.L., Burnett, J.C. Jr., et al. , 1987, Role for intrarenal adenosine in the renal hemodynamic response to contrast media, J. Lab. Clin. Med. 110:406–411.
Lund, H.G., Einzig, S., Rysavy, J., et al. , 1984, Effect of prostaglandin inhibition on the renal vascular response to ionic and non-ionic contrast media in the dog, Acta Radiol. Diag. 25:407–510.
Katzberg, R.W., Morris, T.W., Lasser, E.C., et al. , 1986, Acute systemic and renal hemodynamic effects of meglumine/sodium diatrizoate 75% and iopamidol in euvolemic and dehydrated dogs, Invest. Radiol. 21:193–191.
Messana, J.P., Cieslinski, D.A., Nguyen, V.D., and Humes, H.D., 1988, Comparison of the toxicity of the radiocontrast agents, iopamidol and diatrizoate, to rabbit renal proximal tubule cells in vitro, J. Pharmacol. Exp. Therap. 244:1139–1144.
Humes, H.D., Cieslinski, D.A., and Messana, J.M., 1987, Pathogenesis of radiocontrastinduced acute renal failure: Comparative nephrotoxicity of diatrizoate and iopamidol, Diagn. Imaging (Suppl)12–18, May.
Lund, G., Eihzig, S., Rysavy, J., et al. , 1984, Role of ischemia in contrast-induced renal damage: An experimental study, Circulation 69:783–789.
Weinberg, J.M. and Humes, H.D., 1983, Renal tubule cell integrity during mercuric chloride and gentamicin nephrotoxicity, in: Acute Renal Failure: Correlation between Morphology and Function (K. Solez and A. Whelton, Eds.), Marcel Dekker, New York, pp. 179–194.
Venkatachalam, M.A., 1981, Morphologic factors in acute renal failure, in: Acute Renal Failure (B.M. Brenner and J.H. Stein, Eds.), Churchill Livingstone, New York, pp. 79–107.
Brezis, M., Rosen, S., Silva, P., and Epstein, F.H., 1984, Selective vulnerability of the medullary thick ascending limb to anoxia in the isolated perfused rat kidney, J. Clin. Invest. 73:182–189.
Humes, H.D. and Weinberg, J.M., 1983, Alterations in renal tubular cell metabolism in acute renal failure, Mineral Electrolyte Metab. 9:290–305.
Humes, H.D. and Weinberg, J.M., 1983, Cellular energetics in acute renal failure, in: Acute Renal Failure (B.M. Brenner and J.M. Lazarus, Eds.), Saunders, Philadelphia, pp. 47–98.
Siegel, M., Rice, J., Barnes, J., Osgood, R., and Stein, J., 1983, Protective effect of mini dose ouabain in ischemic renal failure in the dog, Clin. Res. 31:518A.
Weinberg, J.M., 1985, Oxygen deprivation-induced injury to isolated rabbit kidney tubules, J. Clin. Invest. 76:1193–1208.
Brezis, M., Rosen, S., Silva, P., Spokes, K., and Epstein, F.H., 1984, Polyene toxicity in renal medulla: Injury mediated by transport activity, Science 224:66–68.
Gaudio, K.M., Taylor, M.R., Chaudry, I.H., Kashgarian, M., and Siegel, N.J., 1982, Accelerated recovery of single nephron function by the post ischemic infusion of ATP-MGC12, Kidney Int. 22:13–20.
Gaudio, K.M., Ardito, T.A., Reilly, H.F., Kashgarian, M., and Siegel, N.J., 1983, Accelerated cellular recovery after ischemic renal injury, Am. J. Pathol. 112:338–346.
Siegel, N.J., Glazier, W.B., Chaudry, I.H., Gaudin, K.M., Lytton, B., Baue, A.E., and Kashgarian, M., 1980, Enhanced recovery from acute renal failure by the postischemic infusion of adenine nucleotides and magnesium chloride in rats, Kidney Int. 17:338–349.
Weinberg, J.M. and Humes, H.D., 1986, Increases of cell ATP produced by exogenous adenine nucleotides in isolated rabbit renal tubules, Am. J. Physiol. 250:F720–F733.
Venkatachalam, M.A., Patel, Y.J., Kreisberg, J.I., and Weinberg, J.M., 1988, Energy thresholds that determine membrane integrity and injury in a renal epithelial cell line (LLC-PK1), Relationships to phospholipid degradation and unesterified fatty acid accumulation, J. Clin. Invest. 31:745–758.
Nguyen, V.D., Cieslinski, D.A., and Humes, H.D., 1988, Importance of adenosine triphosphate in phospholipase A2 induced rabbit renal proximal tubule cell injury, J. Clin. Invest. 82:1098–1105.
Weinberg, J.M., 1988, Adenine nucleotide metabolism by isolated kidney tubules during oxygen deprivation, Biochem. Med. Met. Biol. 39: 319–329.
Epps, D.E., Palmer, J.W., Schmid, H.H.O., and Pfeiffer, D.R., 1982, Inhibition of permeability- dependent Ca2+ release from mitochondria by N-acylethanolamines, a class of lipids synthesized in ischemic heart tissues, J. Biol. Chem. 257:1383–1391.
Beatrice, M.C., Palmer, J.W., and Pfeiffer, D.R., 1980, The relationship between mitochondrial membrane permeability, membrane potential, and the retention of Ca2+ by mitochondria hydroperoxide, J. Biol. Chem. 255:8663–8671.
Beatrice, M.C., Stiers, D.L., and Pfeiffer, D.R., 1982, Increased permeability of mitochondria during Ca2+ release induced by f-butyl hydroperoxide or oxalacetate, the effect of ruthenium red, J. Biol. Chem. 257:7161–7170.
Chien, K.R., Abrams, J., Serroni, A. et al. , 1978, Accelerated phospholipid degradation and associated membrane dysfunction in irreversible, ischemic liver cell injury, J. Biol. Chem. 253: 4809–4817.
Humes, H.D., 1986, Role of calcium in pathogenesis of acute renal failure, Am. J. Physiol. 250: F579–F589.
Weinberg, J.M. and Humes, H.D., 1985, Calcium transport and inner mitochondrial membrane damage in renal cortical mitochondria, Am. J. Physiol. 248:F876–F889.
Broekemeier, K.M., Schmid, P.C., Schmid, H.H., and Pfeiffer, D.R., 1985, Effects of phospholipase A2 inhibitors on ruthenium red-induced Ca2+ release from mitochondria, J. Biol. Chem. 260:105–113.
Okayasu, T., Curtis, M.T., and Farber, J.L., 1985, Structural alterations of the inner mitochondrial membrane in ischemic liver cell injury, Arch. Biochem. Biophys. 236:638–645.
Palmer, J.W., Schmid, P.C., Pfeiffer, D.R., and Schmid, H. O., 1981, Lipids and lipolytic enzyme activities of rat heart mitochondria, Arch. Biochem. Biophys. 221:674–682.
Malis, C.D. and Bon ventre, J.V., 1986, Mechanism of calcium potentiation of oxygen free radical injury to renal mitochondria, J. Biol. Chem. 261: 14201–14208.
Braughler, J.M., Duncan, L.A., and Goodman, T.J., 1985, Calcium enhances in vitro free radical-induced damage to brain synaptosomes, mitochondria, and cultured spinal cord neurons, J. Neurochem. 45:1288–1293.
Au, A.M., Chan, P.H., and Fishman, R.A., 1985, Stimulation of phospholipase A2 activity by oxygen-derived free radicals in isolated brain capillaries, J. Cell Biochem. 27:449–453.
DiMonte, D., Bellomo, G., Thor, H., Nicotera, P., and Orrenius, S., 1984, Menadione-induced cytotoxicity is associated with protein thiol oxidation and alteration in intracellular Ca2+ homeostasis, Arch. Biochem. Biophys. 235:343–350.
Weglicki, W.B., Dickens, B.F., and Mak, I.T., 1984, Enhanced lysosomal phospholipid degradation and lysophospholipid production due to free radicals, Biochem. Biophys. Res. Commun. 124:229–235.
Sevanian, A., Stein, R.A., and Mead, J.F., 1981, Metabolism of epoxidized phosphatidylcholine by phospholipase A2 and epoxide hydrolase, Lipids 16:781–789.
Humes, H.D. and Weinberg, J.M., 1986, Toxic nephropathies, in: The Kidney, 3rd ed. (B.M. Brenner and F.C. Rector, Eds.), Saunders, Philadelphia, pp. 1491–1532.
Nohl, H., Jordan, W., and Youngman, R.J., 1986, Quinones in biology: Function in electron transfer and oxygen activation, Adv. Free Radical Biol. Med. 2:211–279.
Mak, I.T., Kramer, J.H. and Weglicki, W.B., 1986, Potentiation of free radical-induced lipid peroxidative injury to sarcolemmal membranes by lipid amphiphiles, J. Biol. Chem. 261:1153–1157.
Cross, Carroll E., Halliwell, B., Borish, E.T., Pryor, W.A., Ames, B.N., Saul, R.L., McCord, J.M., and Harman, D. 1987, Oxygen radicals and human disease, Ann. Intern. Med. 107:526–545.
Baud, L. and Ardaillou, R., 1986, Reactive oxygen species: Production and role in the kidney, Am. J. Physiol. 251:F765–F776.
Ward, P.A., Johnson, K.J. and Till, G.O., 1986, Oxygen radicals and microvascular injury of lungs and kidneys, Acta Physiol. Scand. 548(Suppl)79–85.
Ratych, R.E. and Bulkey, G.B., 1986, Free-radical-mediated postischemic reperfusion injury in the kidney, J. Free Radical Biol. Med. 2:311–319.
Fridovich, I., 1978, The biology of oxygen radicals. The superoxide radical is an agent of oxygen toxicity: Superoxide dismutases provide an important defense, Science 201:875–880.
McCord, J.M. and Fridovich, I., 1978, The biology and pathology of oxygen radicals, Ann. Intern. Med. 89:122–127.
Fridovich, I., 1983, Superoxide radical: An endogenous toxicant, Annu. Rev. Pharmacol. Toxicol. 23:239–257.
Reed, D.J. and Fariss, M., 1984, Glutathione depletion and susceptibility, Pharmacol. Rev. 36(2)25S–33S.
Suttorp, N., Toepfer, W., and Roka, L., 1986, Antioxidant defense mechanisms of endothelial cells: Glutathione redox cycle versus catalase, Am. J. Physiol. 251:C671–C680.
Jones, D.P., Eklow, L., Thor, H., and Orrenous, S., 1981, Metabolism of hydrogen peroxide in isolated hepatocytes: Relative contributions of catalase and glutathione peroxidase in decomposition of endogenously generated H2O2, Arch. Biochem. Biophys. 210(2)505–516.
Eklow, L., Moldeus, P., and Orrenous, S., 1984, Oxidation of glutathione during hydroperoxide metabolism, Eur. J. Biochem. 138:459–463.
Freeman, B.A. and Crapo, J.D., 1982, Free radicals and tissue injury, Lab. Invest. 47:412–426.
Guarnieri, C., Flamigni, F., and Caldarere, C.M., 1980, Role of oxygen in the cellular damage induced by re-oxygenation of hypoxic heart, J. Mol. Cell. Cardiol. 12:797–808.
Liu, J., Simon, L.W., Phillips, J.R., and Robin, E.D., 1977, Superoxide dismutase activity in hypoxic mammalian systems, J. Appl. Physiol. 42:107–110.
McCord, J.M., 1985, Oxygen-derived free radicals in postischemic tissue injury, N. Engl. J. Med. 312:159–163.
Engerson, T.D., McDelvey, T.G., Rhyne, D.B., Boggio, E.B., Snyder, S.J., and Jones, H.P., 1987, Conversion of xanthine dehydrogenase to oxidase in ischemic rat tissue, J. Clin. Invest. 79: 1564–1570.
Nohl, H. and Jordan, W., 1986, The mitochondrial site of superoxide formation, Biochem. Biophys. Res. Commun. 138(2)533–539.
Weiss, S.J. and Silvka, A., 1981, Monocyte and granulocyte-mediated tumor cell destruction, J. Clin. Invest. 69:255–262.
Klebanoff, S.J., 1980, Oxygen metabolism and the toxic properties of phagocytes, Ann. Intern. Med. 93:480–489.
Gibson, D.D., Hawrylko, J., and McCay, P.B., 1985, GSH-dependant inhibition of lipid peroxidation: Properties of a potent cytosolic system which protects cell membranes, Lipids 20(10)704–411.
Del Maestro, R.F., 1980, An approach to free radicals in medicine and biology, Acta Physiol. Scand. 492:153–168.
Slater, T.F., 1984, Free-radical mechanisms in tissue injury, Biochem. J. 222:1–15.
Sevanian, A. and Hochstein, P., 1985, Mechanisms and consequences of lipid peroxidation in biological systems, Annu. Rev. Nutr. 5:365–390.
Sevanian, A. and Kim, E., 1985, Phospholipase A2 dependant release of fatty acids from peroxidized membranes, J. Free Rad. Biol. Med. 1:263–271.
Maridonneau, I., Braquet, P., and Garay, R.P., 1983, Na+ and K + transport damage induced by oxygen free radicals in human red cell membranes, J. Biol. Chem. 258:3107–3113.
Curtis, M.T., Gilfor, D., and Farber, J.L., 1984, Lipid peroxidation increases the molecular order of microsomal membranes, Arch. Biochem. Biophys. 235:644–649.
Bellomo, G., Mirabelli, F., and Orrenius, S., 1983, Critical role of sulfhydryl group(s) in ATPdependent Ca+ + sequestration by the plasma membrane fraction from rat liver, FEBS Lett. 163: 136–139.
Nicotera, P., Moore, M., Mirabelli, F., Bellomo, G., and Orrenius, S., 1985, Inhibition of hepatocyte plasma membrane Ca 2+-ATPase activity by menadione metabolism and its restoration by thiols, FEBS Lett. 181:149–153.
Di Monte, D., Bellomo, G., Thor, H., Nicotera, P., and Orrenius, S., 1984, Menadione-induced cytotoxicity is associated with protein thiol oxidation and alteration in intracellular Ca 2+ homeostasis, Arch. Biochem. Biophys. 235:343–350.
Messana, J.M., Cieslinski, D.A., O’Connor, R.P., and Humes, H.D., 1988, The role of glutathione in protection against exogenous oxidant injury to rabbit renal proximal tubules, Am. J. Physiol. 255: F874–F884.
Paller, M.S., Hoidal, J.R., and Ferris, T.F., 1984, Oxygen free radicals in ischemic acute renal failure in the rat, J. Clin. Invest. 74:1156–1164.
Ouriel, K., Smedira, N.G., and Ricotta, J.J., 1985, Protection of the kidney after temporary ischemia; free radical scavengers, J. Vase. Surg. 2:49–53.
Baker, G.L., Corry, R.J., and Autor, A.P., 1985, Oxygen free radical induced damage in kidneys subjected to warm ischemia and reperfusion, Ann. Surg. 202(5)628–641.
Paller, M.S. and Hebbel, R.P., 1986, Ethane production as a measure of lipid peroxidation after renal ischemia, Am. J. Physiol. 251:F839-F843.
Paller, M.S., 1986, Hypothroidism protects against free radical damage in ischemic acute renal failure, Kidney Int. 29:1161–1166.
Koyama, I., Bulkley, G.B., Williams, G.M., and Im, M.J., 1985, The role of oxygen free radicals in mediating the reperfusion injury or cold-preserved ischemic kidneys, Transplantation 40(6)590–595.
Green, C.J., Healing, G., Lunec, J., Fuller, B.J., and Simpkin, S., 1986, Evidence of freeradical- induced damage in rabbit kidneys after simple hypothermic preservation and autotransplantation, Transplantation 41(2) 161–165.
Green, C.J., Healing, G., Simpkin, S., Fuller, B.J., and Lunec, J., 1986, Reduced susceptibility to lipid peroxidation in cold ischemic rabbit kidneys after addition of desferrioxamine, mannitol, or uric acid to the flush solution, Cryobiology 23:358–365.
Bennett, J.F., Bry, W.I., Collins, G.M., and Halasz, N.A., 1987, The effects of oxygen free radicals on the preserved kidney, Cryobiology 24:264–269.
Linas, S.L., Whittenburg, D., and Repine, J.E., 1987, O2 metabolites cause reperfusion injury after short but not prolonged renal ischemia, Am. J. Physiol. 253:F685–F691.
Linas, S.L., Shanley, P.F., White, C.W., Parker, N.P., and Repine, J.E., 1987, O2 metabolitemediated injury in perfused kidneys is reflected by consumption of DMTU and glutathione, Am. J. Physiol. 253:F692–F701.
White, M., Hunt, D., Humes, H.D., and Weinberg, J.M., 1985, Effects of allopurinol on ischemic injury to isolated tubules, Kidney Int. 27:239.
Toledo-Pereyra, L.H., Simmons, R.L., Olson, L.C., and Najarian, J.S., 1977, Clinical effect of allopurinol on preserved kidneys: A randomized double-blind study, Ann. Surg. 185:128–131.
Chatterjee, S.N. and Berne, T.V., 1976, Protective effect of allopurinol in renal ischemia, Am. J. Surg. 131:658–659.
Vasko, K.A., DeWall, R.A., and Riley, A.M., 1972, Effect of allopurinol in renal ischemia, Surgery 71:787–790.
Toledo-Pereyra, L.H., Simmons, R.L., and Najarian, J.S., 1974, Effect of allopurinol on the preservation of ischemic kidneys perfused with plasma or plasma substitutes, Ann. Surg. 180:780–782.
Jackson, N.M., O’Connor, R.P., and Humes, H.D., 1986, Response of isolated renal proximal tubule segments to hypoxia-reoxygenation or chemically induced oxidative stress, Toxicologist 6: 269.
Nguyen, V.D., Messana, J.M., Cieslinski, D.A., and Humes, H.D., 1987, Exogenous glutathione supplementation increases cellular glutathione level of renal proximal tubule segments and prevents hypoxia-induced proximal tubule segment injury, Clin. Res. 35:636A.
Nguyen, V.D., Messana, J.M., Cieslinski, D.A., and Humes, H.D., 1988, Effect of glutathione depletion on hypoxia-induced injury to rabbit renal proximal tubule segments, Kidney Int. 33:363.
Author information
Authors and Affiliations
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 1989 Plenum Publishing Corporation
About this chapter
Cite this chapter
Humes, H.D., Messana, J.M. (1989). Acute Renal Failure and Toxic Nephropathy. In: Klahr, S., Massry, S.G. (eds) Contemporary Nephrology. Springer, Boston, MA. https://doi.org/10.1007/978-1-4613-0829-4_8
Download citation
DOI: https://doi.org/10.1007/978-1-4613-0829-4_8
Publisher Name: Springer, Boston, MA
Print ISBN: 978-1-4612-8103-0
Online ISBN: 978-1-4613-0829-4
eBook Packages: Springer Book Archive